To UM home page

Researcher

Drent, M.

Full professor - Personal chair

View graph of relations
1 - 50 out of 152Page size: 50
  1. 2019
  2. Published
    Bast, A., & Drent, M. (2019). The role of vitamin K in the etiology of diffuse alveolar hemorrhage. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 36(3), 251-252.
  3. Published
    Hendriks, C. M. R., Saketkoo, L. A., Elfferich, M. D. P., De Vries, J., Wijnen, P. A. H. M., & Drent, M. (2019). Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability. Lung, 197(4), 407-413. https://doi.org/10.1007/s00408-019-00234-3
  4. Published
    Voortman, M., Hendriks, C. M. R., Elfferich, M. D. P., Bonella, F., Moller, J., De Vries, J., ... Drent, M. (2019). The Burden of Sarcoidosis Symptoms from a Patient Perspective. Lung, 197(2), 163-163. https://doi.org/10.1007/s00408-019-00221-8
  5. Published
    Wijnen, P., Drent, M., Bekers, O., Verschakelen, J., & Bast, A. (2019). VKORC1 and CYP2C9 Polymorphisms: A Case Report in a Dutch Family with Pulmonary Fibrosis. International Journal of Molecular Sciences, 20(5), [1160]. https://doi.org/10.3390/ijms20051160
  6. Published
    Voortman, M., De Vries, J., Hendriks, C. M. R., Elfferich, M. D. P., Wijnen, P. A. H. M., & Drent, M. (2019). EVERYDAY COGNITIVE FAILURE IN PATIENTS SUFFERING FROM NEUROSARCOIDOSIS. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 36(1), 2-10.
  7. Published
    Drent, M., Veltkamp, M., & Bast, A. (2019). THE MYSTERY OF BLACK PETE MAKE-UP: A SARCOID-LIKE FOREIGN-BODY REACTION. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 36(2), 172-173. https://doi.org/10.36141/svdld.v36i2.8329
  8. 2018
  9. Published
    Stern, B. J., Royal, W., Gelfand, J. M., Clifford, D. B., Tavee, J., Pawate, S., ... Baughman, R. P. (2018). Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurology, 75(12), 1546-1553. https://doi.org/10.1001/jamaneurol.2018.2295
  10. Published
    Korsten, P., & Drent, M. (2018). Multisystemic manifestations of sarcoidosis and comorbidities. Current Opinion in Pulmonary Medicine, 24(5), 477-478. https://doi.org/10.1097/MCP.0000000000000505
  11. Published
    Bast, A., Semen, K. O., & Drent, M. (2018). Nutrition and corticosteroids in the treatment of sarcoidosis. Current Opinion in Pulmonary Medicine, 24(5), 479-486. https://doi.org/10.1097/MCP.0000000000000501
  12. Published
    Hendriks, C., Drent, M., Elfferich, M., & De Vries, J. (2018). The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases. Current Opinion in Pulmonary Medicine, 24(5), 495-503. https://doi.org/10.1097/MCP.0000000000000496
  13. Published
    Hendriks, C., Drent, M., De Kleijn, W., Elfferich, M., Wijnen, P., & De Vries, J. (2018). Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: A prospective follow-up study. Respiratory Medicine, 138, S24-S30. https://doi.org/10.1016/j.rmed.2017.11.008
  14. Published
    Drent, M., Wijnen, P., & Bast, A. (2018). Pharmacogenetic variants and vitamin K deficiency: a risk factor or trigger for fibrosing interstitial pneumonias? Current Opinion in Pulmonary Medicine, 24(3), 287-295. https://doi.org/10.1097/MCP.0000000000000467
  15. Published
    de Brouwer, B., Drent, M., van den Ouweland, J. M. W., Wijnen, P. A., van Moorsel, C. H. M., Bekers, O., ... Janssen, R. (2018). Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis. Respiratory Research, 19, [45]. https://doi.org/10.1186/s12931-018-0747-6
  16. Published
    Voortman, M., Beekman, E., Drent, M., Hoitsma, E., & De Vries, J. (2018). Determination Of The Smallest Detectable Change (Sdc) And The Minimal Important Difference (Mid) For The Small Fiber Neuropathy Screening List (Sfnsl) In Sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 35(4), 333-341.
  17. Published
    Fijten, R. R. R., Smolinska, A., Drent, M., Dallinga, J. W., Mostard, R., Pachen, D. M., ... Boots, A. W. (2018). The necessity of external validation in exhaled breath research: a case study of sarcoidosis . Journal of Breath Research, 12(1), [016004]. https://doi.org/10.1088/1752-7163/aa8409
  18. 2017
  19. Published
    Veith, C., Drent, M., Bast, A., van Schooten, F. J., & Boots, A. W. (2017). The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin. Toxicology and Applied Pharmacology, 336, 40-48. https://doi.org/10.1016/j.taap.2017.10.001
  20. Published
    Fritz, D., Voortman, M., van de Beek, D., Drent, M., & Brouwer, M. C. (2017). Many faces of neurosarcoidosis: from chronic meningitis to myelopathy. Current Opinion in Pulmonary Medicine, 23(5), 439-446. https://doi.org/10.1097/MCP.0000000000000401
  21. Published
    Voortman, M., Fritz, D., Vogels, O. J. M., Eftimov, F., van de Beek, D., Brouwer, M. C., & Drent, M. (2017). Small fiber neuropathy: a disabling and underrecognized syndrome. Current Opinion in Pulmonary Medicine, 23(5), 447-457. https://doi.org/10.1097/MCP.0000000000000413
  22. Published
    Deenstra, D., Wolvetang, N., Kock, S., Wills, S., Cobben, N., Wijnen, P., & Drent, M. (2017). Prevalence of interstitial and other lung diseases on Aruba. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 34(3), 217-225.
  23. 2016
  24. Published
    Drent, M., Bast, A., Bootsma, H-P., & Deneer, V. (2016). REPOSITIONING 'OLD' DRUGS TO TREAT RARE DISEASES: ARGUING FROM THE MECHANISM OF ACTION. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 33(2), 191-194.
  25. Published
    van Manen, M. J. G., Wapenaar, M., Strookappe, B., Drent, M., Elfferich, M., de Vries, J., ... Wijsenbeek, M. S. (2016). VALIDATION OF THE KING'S SARCOIDOSIS QUESTIONNAIRE (KSQ) IN A DUTCH SARCOIDOSIS POPULATION. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 33(1), 75-82.
  26. 2015
  27. Published
    Marcellis, R. G. J., van der Veeke, M. A. F., Mesters, I., Drent, M., de Bie, R. A., de Vries, G. J., & Lenssen, A. F. (2015). Does physical training reduce fatigue in sarcoidosis? Sarcoidosis Vasculitis and Diffuse Lung Diseases, 32(1), 53-62.
  28. Published
    de Raadt, W. M., Wijnen, P. A., Bast, A., Bekers, O., & Drent, M. (2015). Acute eosinophilic pneumonia associated with glyphosate-surfactant exposure. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 32(2), 172-175.
  29. 2013
  30. Published
    Vanspauwen, M. J., Schnabel, R. M., Bruggeman, C. A., Drent, M., van Mook, W. N., Bergmans, D. C., & Linssen, C. F. (2013). Mimivirus is not a frequent cause of ventilator-associated pneumonia in critically ill patients. Journal of Medical Virology, 85(10), 1836-1841. https://doi.org/10.1002/jmv.23655
  31. Published
    Cremers, J. P., Drent, M., Bast, A., Shigemitsu, H., Baughman, R. P., Valeyre, D., ... Jansen, T. L. (2013). Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Current Opinion in Pulmonary Medicine, 19(5), 545-561. https://doi.org/10.1097/MCP.0b013e3283642a7a
  32. Published
    Mostard, R. L. M., van Kroonenburgh, M. J. P. G., & Drent, M. (2013). The role of the PET scan in the management of sarcoidosis. Current Opinion in Pulmonary Medicine, 19(5), 538-544. https://doi.org/10.1097/MCP.0b013e328363ed0d
  33. Published
    Mostard, R. L. M., Verschakelen, J. A., van Kroonenburgh, M. J. P. G., Nelemans, P. J., Wijnen, P. A. H. M., Voo, S., & Drent, M. (2013). Severity of pulmonary involvement and F-18-FDG PET activity in sarcoidosis. Respiratory Medicine, 107(3), 439-447. https://doi.org/10.1016/j.rmed.2012.11.011
  34. Published
    Wijnen, P. A. H. M., Verschakelen, J. A., Bast, A., Bekers, O., & Drent, M. (2013). Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger? Lung, 191(1), 53-59. https://doi.org/10.1007/s00408-012-9436-2
  35. Published
    Cremers, J. P., Drent, M., Elfferich, M. D., Nelemans, P. J., Wijnen, P. A., Witteman, B. J., & Schols, A. M. (2013). Body composition profiling in a Dutch sarcoidosis population. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 30(4), 289-299.
  36. 2012
  37. Published
    Drent, M., Wijnen, P., & Bast, A. (2012). Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy. Current Medicinal Chemistry, 19(33), 5607-5611. https://doi.org/10.2174/092986712803988901
  38. Published
    Mostard, R. L., van Kuijk, S. M., Verschakelen, J. A., van Kroonenburgh, M. J., Nelemans, P. J., Wijnen, P. A. H. M., & Drent, M. (2012). A predictive tool for an effective use of 18F-FDG PET in assessing activity of sarcoidosis. BMC Pulmonary Medicine, 12(12), 57-(electr). [57]. https://doi.org/10.1186/1471-2466-12-57
  39. Published
    Drent, M., Lower, E. E., & De Vries, J. (2012). Sarcoidosis-associated fatigue. European Respiratory Journal, 40(1), 255-263. https://doi.org/10.1183/09031936.00002512
  40. Published
    Erckens, R. J., Mostard, R. L. M., Wijnen, P., Schouten, J. S., & Drent, M. (2012). Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefe's Archive for Clinical and Experimental Ophthalmology, 250(5), 713-720. https://doi.org/10.1007/s00417-011-1844-0
  41. Published
    Drent, M., Wijnen, P. A. H. M., Boots, A. W., & Bast, A. (2012). Cat litter is a possible trigger for sarcoidosis. European Respiratory Journal, 39(1), 221-222. https://doi.org/10.1183/09031936.00074411
  42. Published
    Mostard, R. L., Prompers, L., Weijers, R. E., van Kroonenburgh, M. J., Wijnen, P. A., Geusens, P. P., & Drent, M. (2012). F-18 FDG PET/CT for Detecting Bone and Bone Marrow Involvement in Sarcoidosis Patients. Clinical Nuclear Medicine, 37(1), 21-25. https://doi.org/10.1097/RLU.0b013e3182335f9b
  43. Published
    Cremers, J., Drent, M., Driessen, A., Nieman, F., Wijnen, P. A., Baughman, R., & Koek, G. (2012). Liver-test abnormalities in sarcoidosis. European Journal of Gastroenterology & Hepatology, 24(1), 17-24. https://doi.org/10.1097/MEG.0b013e32834c7b71
  44. Published
    Drent, M., & Bast, A. (2012). Management van longfibrose: Stand van zaken. Farmacotherapie Online, 1, 9.
  45. Published
    Cremers, J. P., Drent, M., Baughman, R. P., Wijnen, P. A. H. M., & Koek, G. H. (2012). Therapeutic approach of hepatic sarcoidosis. Current Opinion in Pulmonary Medicine, 18(5), 472-482. https://doi.org/10.1097/MCP.0b013e3283541626
  46. 2011
  47. Published
    de Kleijn, W. P., Drent, M., Vermunt, J. K., Shigemitsu, H., & de Vries, J. (2011). Types of fatigue in sarcoidosis patients. Journal of Psychosomatic Research, 71(6), 416-422. https://doi.org/10.1016/j.jpsychores.2011.09.006
  48. Published
    Westers Attema, A., Veraart, J. C. J. M., de Pont, C. D., Mostard, R. L., Voo, S. A., van Kroonenburgh, M. J., & Drent, M. (2011). Pet scan: Findings in a patient with severe cutaneous and systemic sarcoidosis. Clinical Nuclear Medicine, 36(11), 1049-1050. https://doi.org/10.1097/RLU.0b013e3182291c51
  49. Published
    Marcellis, R. G., Lenssen, A. F., Elfferich, M. D., de Vries, J., Kassim, S., Foerster, K., & Drent, M. (2011). Exercise capacity, muscle strength and fatigue in sarcoidosis. European Respiratory Journal, 38(3), 628-634. https://doi.org/10.1183/09031936.00117710
  50. Published
    de Kleijn, W. P., de Vries, J., Wijnen, P. A. H. M., & Drent, M. (2011). Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. Respiratory Medicine, 105(9), 1388-1395. https://doi.org/10.1016/j.rmed.2011.05.004
  51. Published
    Loza, M. J., Brodmerkel, C., du Bois, R. M., Judson, M. A., Costabel, U., Drent, M., ... Baughman, R. P. (2011). Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis. Clinical and Vaccine Immunology, 18(6), 931-939. https://doi.org/10.1128/CVI.00337-10
  52. Published
    Wijnen, P. A. H. M., Voorter, C. E., Nelemans, P. J., Verschakelen, J. A., Bekers, O., & Drent, M. (2011). Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression? Human Immunology, 72(4), 342-347. https://doi.org/10.1016/j.humimm.2011.01.011
  53. Published
    Vanspauwen, M. J., Linssen, C. F. M., Bruggeman, C. A. M. V. A., Jacobs, J. A., Drent, M., Bergmans, D. C., & van Mook, W. N. (2011). Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia? Critical Care, 15(1), 1-8. [14]. https://doi.org/10.1186/cc9418
  54. Published
    Baughman, R. P., Nagai, S., Balter, M., Costabel, U., Drent, M., du Bois, R., ... Teirstein, A. (2011). Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 28(1), 56-64.
  55. Published
    Wijnen, P. A. H. M., Bekers, O., & Drent, M. (2011). Development of Cocaine-Induced Interstitial Lung Damage in Two CYP2C and VKORC1 Variant Allele Carriers. Molecular Diagnosis & Therapy, 15(3), 177-180. https://doi.org/10.1007/BF03256408
  56. Published
    Mostard, R. L., Vöö, S., van Kroonenburgh, M. J. P. G., Verschakelen, J. A., Wijnen, P. A. H. M., Nelemans, P. J., ... Drent, M. (2011). Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respiratory Medicine, 105(12), 1917-1924. https://doi.org/10.1016/j.rmed.2011.08.012
  57. Published
    Boots, A. W., Drent, M., de Boer, V. C., Bast, A., & Haenen, G. R. M. M. (2011). Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clinical Nutrition, 30(4), 506-512. https://doi.org/10.1016/j.clnu.2011.01.010
  58. Published
    Hoitsma, E., de Vries, J., & Drent, M. (2011). The small fiber neuropathy screening list: Construction and cross-validation in sarcoidosis. Respiratory Medicine, 105(1), 95-100. https://doi.org/10.1016/j.rmed.2010.09.014
Previous 1 2 3 4 Next

UM personal profile

UM postal address
P.O. Box 616
6200 MD Maastricht
The Netherlands

UM visiting address
Minderbroedersberg 4-6
6211 LK Maastricht
The Netherlands
Phone: +31 43 388 2222

Quick Links